News & Updates
Filter by Specialty:
Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
18 May 2022
In the treatment of young infants with nonbacteraemic urinary tract infection (UTI), administering intravenous (IV) antibiotics for less than 48 hours appears to work well in the absence of meningitis, with low rates of treatment failure and serious complications, according to a study.
Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
18 May 2022
SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes
18 May 2022
Treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) leads to lower rates of cardiovascular disease (CVD) events in patients with type 2 diabetes mellitus (T2DM) than does dipeptidyl peptidase-4 inhibitors (DPP4i), reports a recent Japan study.